Back to Forecasting
CC Forecast Markets
The Chemours Company
7
Active Markets
26%
Avg Probability
All Markets
7 markets
Will the North Carolina PFAS bellwether trial return an adverse verdict against Chemours by 2026-09-30?
32%
Likely No
88% agreement
Sep 30, 2026
IG: 0.80
Will Chemours disclose material findings from the audit committee internal review by year-end 2026?
18%
Likely No
85% agreement
Dec 31, 2026
IG: 0.80
Will Chemours TT segment Adjusted EBITDA margin print below 5% in any quarter of 2026?
38%
Likely No
90% agreement
Mar 15, 2027
IG: 0.64
Will the EU PFAS final rule be published without a fluoropolymer/polymer-of-low-concern carve-out by 2026-12-31?
15%
Likely No
88% agreement
Dec 31, 2026
IG: 0.64
Will Chemours disclose DuPont MOU remaining capacity below $500M (its $2B share) by 2026-12-31?
28%
Likely No
87% agreement
Dec 31, 2026
IG: 0.60
Will the civil RICO motion to dismiss against Chemours be granted (fully or in material part) by 2026-12-31?
32%
Likely No
82% agreement
Dec 31, 2026
IG: 0.60
Will TSS segment trailing-twelve-months Adjusted EBITDA fall below $600M as disclosed by the Q3 2026 10-Q?
22%
Likely No
90% agreement
Nov 30, 2026
IG: 0.48
Resolution Timeline
Sep 30, 2026
Will the North Carolina PFAS bellwether trial return an adverse verdict against Chemours by 2026-09-30?Prediction: 32%
Nov 30, 2026
Will TSS segment trailing-twelve-months Adjusted EBITDA fall below $600M as disclosed by the Q3 2026 10-Q?Prediction: 22%
Dec 31, 2026
Will Chemours disclose material findings from the audit committee internal review by year-end 2026?Prediction: 18%
Dec 31, 2026
Will Chemours disclose DuPont MOU remaining capacity below $500M (its $2B share) by 2026-12-31?Prediction: 28%
Dec 31, 2026
Will the civil RICO motion to dismiss against Chemours be granted (fully or in material part) by 2026-12-31?Prediction: 32%
Mar 15, 2027
Will Chemours TT segment Adjusted EBITDA margin print below 5% in any quarter of 2026?Prediction: 38%